Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

  • RnM2474174
  • |
  • 11 October, 2018
  • |
  • 86 pages
  • |
  • GBI Research
  • |
  • Pharmaceuticals & Healthcare
1-user PDF :    $6,995.00
1-5 User PDF :   $13,990.00
Enterprise PDF :    $20,985.00

Check Discount on this report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,322.97
10,645.94
15,968.91
6,323.23
12,646.46
18,969.68
759,454.15
1,518,908.29
2,278,362.44
497,558.55
995,117.09
1,492,675.64
Credit card Logo